These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9279879)

  • 21. Asymmetries of benzodiazepine receptor binding potential in the inferior medial temporal lobe and cerebellum detected with 123I-iomazenil SPECT in comparison with 99mTc-HMPAO SPECT in patients with partial epilepsy.
    Kuji I; Sumiya H; Tsuji S; Ichikawa A; Tonami N
    Ann Nucl Med; 1998 Aug; 12(4):185-90. PubMed ID: 9795703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 3)--Report on clinical usefulness in epilepsy].
    Torizuka K; Uemura K; Toru M; Shinohara Y; Nishimura T; Yonekura Y; Nakagawara J; Matsuda H; Sakai F; Matsuda K; Fukuyama H; Morimoto K
    Kaku Igaku; 1996 Mar; 33(3):319-28. PubMed ID: 8622265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Parametric images of central-type benzodiazepine receptor binding and ligand transport by two SPECT scans of 123I-iomazenil: relative quantification without blood data].
    Onishi Y; Yonekura Y; Tanaka F; Nishizawa S; Okazawa H; Ishizu K; Fujita T; Konishi J; Mukai T
    Kaku Igaku; 1996 Sep; 33(9):953-63. PubMed ID: 8921663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased benzodiazepine receptor binding in Machado-Joseph disease.
    Ishibashi M; Sakai T; Matsuishi T; Yonekura Y; Yamashita Y; Abe T; Ohnishi Y; Hayabuchi N
    J Nucl Med; 1998 Sep; 39(9):1518-20. PubMed ID: 9744334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of central benzodiazepine receptor binding potential in the brain with 123I-iomazenil SPECT: technical and interobserver variability.
    Verhoeff NP; Erbas B; Kapucu O; Busemann Sokole E; Blok H; Van Royen EA
    Nucl Med Commun; 1993 Aug; 14(8):634-43. PubMed ID: 8396758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 2)--Report on clinical usefulness in diagnosis of degenerative neurological diseases and mental disorders].
    Torizuka K; Uemura K; Toru M; Shinohara Y; Nishimura T; Yonekura Y; Nakagawara J; Matsuda H; Sakai F; Matsuda K; Fukuyama H; Morimoto K
    Kaku Igaku; 1996 Mar; 33(3):303-18. PubMed ID: 8622264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postcarotid endarterectomy improvement in cognition is associated with resolution of crossed cerebellar hypoperfusion and increase in 123I-iomazenil uptake in the cerebral cortex: a SPECT study.
    Chida K; Ogasawara K; Aso K; Suga Y; Kobayashi M; Yoshida K; Terasaki K; Tsushina E; Ogawa A
    Cerebrovasc Dis; 2010; 29(4):343-51. PubMed ID: 20130400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A method for the quantification of benzodiazepine receptors by using 123I-iomazenil and SPECT with one scan and one blood sampling.
    Ito H; Kawashima R; Koyama M; Goto R; Sato K; Ono S; Fukuda H
    Ann Nucl Med; 1997 May; 11(2):101-8. PubMed ID: 9212889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of the SPECT benzodiazepine receptor radioligand [123I]iomazenil in human and non-human primates.
    Zoghbi SS; Baldwin RM; Seibyl JP; al-Tikriti MS; Zea-Ponce Y; Laruelle M; Sybirska EH; Woods SW; Goddard AW; Malison RT
    Int J Rad Appl Instrum B; 1992 Nov; 19(8):881-8. PubMed ID: 1330992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 4)--Report on clinical usefulness in diagnosis of cerebrovascular diseases].
    Torizuka K; Uemura K; Toru M; Shinohara Y; Nishimura T; Yonekura Y; Nakagawara J; Matsuda H; Sakai F; Matsuda K; Fukuyama H; Morimoto K
    Kaku Igaku; 1996 Mar; 33(3):329-44. PubMed ID: 8622266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Impairment of benzodiazepine receptor in Parkinson's disease evaluated by 123I-iomazenil SPECT].
    Kawabata K; Tachibana H; Sugita M; Fukuchi M
    Kaku Igaku; 1996 Apr; 33(4):391-7. PubMed ID: 8683878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iodine-123-iomazenil and iodine-123-iodoamphetamine SPECT in major cerebral artery occlusive disease.
    Moriwaki H; Matsumoto M; Hashikawa K; Oku N; Ishida M; Seike Y; Fukuchi K; Hori M; Nishimura T
    J Nucl Med; 1998 Aug; 39(8):1348-53. PubMed ID: 9708504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Benzodiazepine receptor imaging in the brain: recent developments and clinical validity].
    Morimoto K
    Kaku Igaku; 1999 May; 36(4):307-13. PubMed ID: 10390953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased benzodiazepine receptor and increased GABA level in cortical tubers in tuberous sclerosis complex.
    Mori K; Mori T; Toda Y; Fujii E; Miyazaki M; Harada M; Kagami S
    Brain Dev; 2012 Jun; 34(6):478-86. PubMed ID: 21959128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Similarity and robustness of PET and SPECT binding parameters for benzodiazepine receptors.
    Millet P; Graf C; Buck A; Walder B; Westera G; Broggini C; Arigoni M; Slosman D; Bouras C; Ibáñez V
    J Cereb Blood Flow Metab; 2000 Nov; 20(11):1587-603. PubMed ID: 11083234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epileptic negative myoclonus: a combined study of EEG and [123I]iomazenil (123I-IMZ) single photon emission computed tomography indicating involvement of medial frontal area.
    Usui K; Matsuda K; Terada K; Nikaido K; Matsuhashi M; Nakamura F; Umeoka S; Usui N; Tottori T; Baba K; Inoue Y
    Epilepsy Res; 2010 May; 89(2-3):220-6. PubMed ID: 20133106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of iodine-123-iomazenil SPECT and technetium-99m-HMPAO-SPECT in Alzheimer's disease.
    Fukuchi K; Hashikawa K; Seike Y; Moriwaki H; Oku N; Ishida M; Fujita M; Uehara T; Tanabe H; Kusuoka H; Nishimura T
    J Nucl Med; 1997 Mar; 38(3):467-70. PubMed ID: 9074540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decrease in benzodiazepine receptor binding in a patient with Angelman syndrome detected by iodine-123 iomazenil and single-photon emission tomography.
    Odano I; Anezaki T; Ohkubo M; Yonekura Y; Onishi Y; Inuzuka T; Takahashi M; Tsuji S
    Eur J Nucl Med; 1996 May; 23(5):598-604. PubMed ID: 8698070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different sensitivities to competitive inhibition of benzodiazepine receptor binding of 11C-iomazenil and 11C-flumazenil in rhesus monkey brain.
    Inoue O; Hosoi R; Kobayashi K; Itoh T; Gee A; Suzuki K
    Ann Nucl Med; 2001 Apr; 15(2):137-9. PubMed ID: 11448072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual-isotope autoradiographic measurement of regional blood flow and benzodiazepine receptor availability following unilateral middle cerebral artery occlusion.
    al-Tikriti MS; Dey HM; Zoghbi SS; Baldwin RM; Zea-Ponce Y; Innis RB
    Eur J Nucl Med; 1994 Mar; 21(3):196-202. PubMed ID: 8200386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.